World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

A COMPERATIVE STUDY OF ‘VIRECHANA KARMA’AND ‘VRIDDHA DARVADHYA LOHAM’ WITH ‘ERAND SNEHA’ IN THE MANAGEMENT OF AMAVATA W.S.R. TO RHEUMATOID ARTHRITIS – A RESEARCH ARTICLE

Dr. Jyoti Dhakar*, Dr. Pramod Kumar Mishra, Dr. Brahmanand sharma and Mangal Singh

ABSTRACT

Introduction: Ayurveda has taken the foremost place in the management of crippling disease. Amavata, which can be correlate with Rheumatoid arthritis due to its clinical appearance. Due to wide spectrum of disease, much prevalence and lack of effective medicine, so disease being chosen for the study. Prevalence of approx. 0.75% of the population in india. Aims & objectives: To Study the „Virechana Karma?and „Vriddha Darvadhya Loham? with „Erand Sneha? in the management of Amavata W.S.R. to Rheumatoid Arthritis. Methods and Material: 20 clinically diagnosed patients of Amavata treated by vriddha darvadhya loham 2 capsules (each 500 mg) two times in a day with lukewarm water, for 30 days and„Eranda snehapan?10-20 ml with lukewarm milk according to kostha & bala of the patients at night,for 30 days in group A. And 20 clinicallly diagnosed patients of amavata treated by virechana karma followed by vriddha darvadhya loham 2 capsules (each 500 mg) two times in a day with lukewarm water, for 30 days and„Eranda snehapan?10-20 ml with lukewarm milk according to kostha & bala of the patients at night,for 30 days in group B. Study Design- Single centre and Open Clinical study. Results: In group A - Excellent relief was found in 0% of patients, significant relief in 10%, moderate relief in 65% whereas 25% were found mild relief, while in group B-Excellent relief was found in 5% of patients, significant relief in 35%, moderate relief in 50% whereas 10 %were found mild relief. Conclusions: On comparing the effect of two groups it can be concluded that Group B („Virechana karma & Vriddha darvadhya loham & Erand Sneha) provided better relief than Gr oup A („ Vriddha darvaddhya loham & Erand sneha?) in most of the sign and symptom of the disease at significant level.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR